Return to PJ Online Home Page
The Pharmaceutical Journal Vol 265 No 7122 p716
November 11, 2000 Letters

Physician-assisted suicide

Debate among pharmacists needed

From Miss E. A. Hackett, MRPharmS, and Miss S. A. Francis, MRPharmS

SIR,—We were pleased to read Weiss and Hanlon’s recent article calling for the profession of pharmacy to engage in debate regarding the role of pharmacists in physician-assisted suicide (PAS).1 Research conducted in Britain among general practitioners and hospital consultants found that doctors do receive requests by patients actively to hasten death and that some doctors have complied with these requests.2 We believe it is reasonable to question whether pharmacists are dispensing the drugs implicated, knowingly or unknowingly.
We have recently completed a survey of 288 hospital and community pharmacists that investigated their views and experiences of requests for, and involvement in, PAS and voluntary active euthanasia (VAE). Our preliminary findings echo those of Hanlon et al.3 We found that about a third of respondents did not want to know the purpose of the drugs they were dispensing if they were intended for PAS and/or VAE. A similar number of respondents reported that it was acceptable for a prescriber to withhold the intended purpose of these drugs from the pharmacist. A quarter of the respondents stated that they would knowingly dispense drugs intended for PAS or VAE at the present time. The data suggested that some pharmacists were unaware of the possible legal implications resulting from such involvement. For this reason in particular we would like to encourage our professional body to discuss these issues.
We believe that belonging to the pharmacy profession includes resolving ethical dilemmas and making professional judgments in the best interests of each individual patient. We do not wish to be protocol-driven; we want our involvement in pharmaceutical care to be more than a “McPharmacy experience”.4 As Weiss and Hanlon requested,1 let us take the initiative now and grasp the opportunity to debate this issue openly before future legislation dictates our role.

Elizabeth Hackett
Sally Anne Francis
Centre for Practice and Policy,
School of Pharmacy,
University of London

References

  1. Weiss M, Hanlon T. A role for the pharmacist in physician-assisted suicide? Pharm J 2000;265:649.
  2. Ward BJ, Tate PA. Attitudes among NHS doctors to requests for euthanasia. BMJ 1994;308:1332-4.
  3. Hanlon TRG, Weiss MC, Rees JR. British community pharmacists’ views of physician-assisted suicide. J Med Ethics 2000. In press.
  4. Harding G, Taylor K. The McDonaldisation of pharmacy. Pharm J 2000;265: 602.